November 2003

Introduction

In October, the US Food and Drug Administration (FDA) approved another agent as a counterterrorism measure, Radiogardase. Also approved was Namenda (memantine) as a novel treatment of moderate to severe dementia of the Alzheimer's type.

This month's column reviews FDA new product approvals and labeling changes for:

Alzheimer's disease

Namenda (memantine HCl) Tablets

Antidiabetic agents

Starlix (nateglinide) Tablets

Antidepressants

Paxil CR (paroxetine HCl) Tablets

Antiviral agents

Lexiva (fosamprenavir) Tablets Rebetol (ribavirin) Capsules

Cardiovascular agents

Inspra (eplerenone) Tablets

Counterterrorism agents

Radiogardase (Insoluble Prussian Blue) Capsules

Estrogens

Estrasorb (estradiol) Topical Emulsion

Ophthalmic Agents

Elestat (epinastine HCI) Ophthalmic Solution

Medscape Pharmacists. 2003;4(2) © 2003 Medscape

Cite this: November 2003 - Medscape - Nov 13, 2003.